Asia Pacific and Russia Diagnostic Study for EGFR Testing

Clinical trial NCT01788163 · COMPLETED

Trial details

NCT number: NCT01788163
Sponsor: AstraZeneca
Status: COMPLETED
Phase: Not Applicable
Study type: INTERVENTIONAL

EGFR Mutation Status in aNSCLC Patients

Start date: 2013-02-27
Primary completion: 2014-08-25
Enrollment: 3500

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.